002252.SZ Stock Analysis
00
Uncovered
Shanghai RAAS Blood Products Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Shanghai RAAS Blood Products Co., Ltd. engages in the research and development, production and sales of blood products. The company is headquartered in Shanghai, Shanghai and currently employs 2,966 full-time employees. The company went IPO on 2008-06-23. The firm's main products include human albumin and human immunoglobulin for intravenous injection, human coagulation factors and others. The firm is also engaged in the distribution of Chinese medicine products and foods. The firm distributes its products within domestic market and to overseas markets.